Pregnant patients, harbouring a BRAF V600E mutation—the most abundant mutation in melanoma—were described as developing extensive metastatic melanoma during pregnancy or in the first year after birth, with poor survival regardless of therapeutic interventions [47]. This evidence concerns the gene BRAF and metastatic melanoma.